Details of the Drug Formulations

General Information of Drug (ID: DM4EWNS)

• Drug Name: Cinoxacin Drug Info
• Synonyms: Cinobac; Cinobactin; Cinoxacine; Cinoxacino; Cinoxacinum; Cinx; Clinoxacin; Uronorm; Azolinic Acid; C 8645; Lilly 64716; TNP00246; Cinobac (TN); Cinoxacine [INN-French]; Cinoxacino [INN-Spanish]; Cinoxacinum [INN-Latin]; Cinoxacin (JAN/USP/INN); Cinoxacin [USAN:BAN:INN:JAN]; 1-Ethyl-1,4-dihydro-4-oxo(1,3)dioxolo(4,5-g)cinnoline-3-carboxylic acid; 1-Ethyl-1,4-dihydro-4-oxo[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid; 1-Ethyl-4-oxo-1,4-dihydro[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid; 1-Ethyl-6,7-methylenedioxy-4(1H)-oxocinnoline-3-carboxylic acid; 1-ethyl-4-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid

Indication

Disease Entry	ICD 11	Status	REF
Urinary tract infection	GC08	Approved	[1]

• Therapeutic Class: Antiinfective Agents
• Cross-matching ID:
  PubChem CID: 2762
  ChEBI ID: CHEBI:3716
  CAS Number: 28657-80-9
  TTD ID: D07UXP
  ACDINA ID: D00947

Full List of Drug Formulations Containing This Drug

Cinoxacin 250mg capsule

Company	Formulation ID	FDA Description
Eli Lilly And Co	F23115	D&C Yellow No 10; Fd&C Blue No 1; Fd&C Red No 3; Fd&C Yellow No 6; Gelatin; Silicon Dioxide; Silicone Fluid; Sodium Lauryl Sulfate; Starch; Titanium Dioxide

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015